BIOCON:NSE
Biocon Ltd
349,20 ₹
arrow_downward
-0,80%(-2,80) 1D
16 қаз., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIOCON...
Open
352,60 ₹
High
353,00 ₹
Low
348,00 ₹
Mkt. cap
568,79 млрд
Avg. vol.
2,97 млн
Volume
1,88 млн
Dividend
0,14%
Quarterly dividend
0,12 ₹
Ex-dividend date
2026 ж. 03 шіл.
P/E ratio
103,38
52-wk high
447,15 ₹
52-wk low
337,70 ₹
EPS
3,38 ₹
Shares outstanding
600,00 млн
No. of employees
16 мың
Open
352,60 ₹
High
353,00 ₹
Low
348,00 ₹
Mkt. cap
568,79 млрд
Avg. vol.
2,97 млн
Volume
1,88 млн
Dividend
0,14%
Quarterly dividend
0,12 ₹
Ex-dividend date
2026 ж. 03 шіл.
P/E ratio
103,38
52-wk high
447,15 ₹
52-wk low
337,70 ₹
EPS
3,38 ₹
Shares outstanding
600,00 млн
No. of employees
16 мың
News stories
From web sources and news partners
Detroit Free Press
·
21 минут бұрын
Memory-chip rout, inflation, CoreWeave: The week on Wall Street
Yahoo Finance
·
53 минут бұрын
Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half
Binance
·
42 минут бұрын
Binance Market Update | S&P 500 Near a Record While Half the Russell 3000 Is in a Bear Market — Bitcoin Held as AI Credit Spreads Blew Out and Strategy Fell 9%
MarketWatch
·
13 сағат бұрын
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16,4 мың
Founded1978 ж. 29 қар.
HeadquartersБангалор, Карнатака, Үндістан
Sector-
Websitebiocon.com